Informa plc (LON:INF – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven brokerages that are covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month target price among analysts that have covered the stock in the last year is GBX 1,097.86.
Several equities analysts have weighed in on the company. JPMorgan Chase & Co. cut their price target on Informa from GBX 1,345 to GBX 1,330 and set an “overweight” rating for the company in a report on Monday, January 12th. Panmure Gordon reissued a “buy” rating and issued a GBX 1,200 target price on shares of Informa in a report on Wednesday, November 19th. Berenberg Bank restated a “buy” rating and issued a GBX 1,030 price target on shares of Informa in a research report on Wednesday, January 21st. UBS Group reaffirmed a “buy” rating and set a GBX 1,055 price target on shares of Informa in a research note on Friday, November 7th. Finally, Citigroup lifted their price target on Informa from GBX 975 to GBX 1,000 and gave the stock a “neutral” rating in a research report on Thursday, January 22nd.
Get Our Latest Analysis on INF
Informa Trading Down 0.8%
Insider Activity
In other news, insider Stephen A. Carter sold 330,249 shares of the company’s stock in a transaction dated Thursday, January 22nd. The shares were sold at an average price of GBX 934, for a total transaction of £3,084,525.66. Insiders own 0.39% of the company’s stock.
Informa Company Profile
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.
Further Reading
- Five stocks we like better than Informa
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.
